Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVANCE DIAGNOSTICS DISPOSABLE EYECUP

K-Number: K881369 · 1988-05-13

ApplicantAdvantage Diagnostics Corp.
Decision Date1988-05-13
Product CodeLXQ
DecisionSubstantially Equivalent

Device Summary

ADVANCE DIAGNOSTICS DISPOSABLE EYECUP is the device name listed in this FDA 510(k) record. The listed applicant is Advantage Diagnostics Corp.. It received FDA 510(k) clearance on 1988-05-13 under 510(k) number K881369. The device is classified under product code LXQ. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVANCE DIAGNOSTICS DISPOSABLE EYECUP?

ADVANCE DIAGNOSTICS DISPOSABLE EYECUP is a medical device that received FDA 510(k) clearance on 1988-05-13. The listed applicant is Advantage Diagnostics Corp.. The 510(k) number is K881369.

When did ADVANCE DIAGNOSTICS DISPOSABLE EYECUP receive FDA 510(k) clearance?

ADVANCE DIAGNOSTICS DISPOSABLE EYECUP received FDA 510(k) clearance on 1988-05-13, under 510(k) number K881369.

Who is the listed applicant for ADVANCE DIAGNOSTICS DISPOSABLE EYECUP?

The FDA 510(k) record lists Advantage Diagnostics Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVANCE DIAGNOSTICS DISPOSABLE EYECUP?

The FDA product code for ADVANCE DIAGNOSTICS DISPOSABLE EYECUP is LXQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Advantage Diagnostics Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K023712ADVANTAGE MULTIPLE DRUGS OF ABUSE TESTK013778PEACE OF MIND HOME DRUG TESTK011962ADVANTAGE MARIJUANA (THC) AND COCAINE HOME DRUG TESTK010921ADVANTAGE MARIJUANA (THC) HOME DRUG TESTK003708ADVANTAGE THC/COCAINE TESTK001567ADVANTAGE THC TEST

View all 10 devices →

Related Devices (Code: LXQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K051414EYE CUP, STERILE 1 AND NON STERILETollot Pty.Ltd.(Aaxis Pacific)K971134VISTA EYESHOWERJohn Branch

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑